Choreo LLC Has $819,000 Holdings in The Clorox Company (NYSE:CLX)

Choreo LLC boosted its position in The Clorox Company (NYSE:CLX) by 12.8% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 5,741 shares of the company’s stock after purchasing an additional 652 shares during the period. Choreo LLC’s holdings in Clorox were worth $819,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of CLX. Kingswood Wealth Advisors LLC acquired a new position in shares of Clorox in the 3rd quarter valued at about $484,000. Robeco Institutional Asset Management B.V. lifted its stake in Clorox by 11.5% in the third quarter. Robeco Institutional Asset Management B.V. now owns 321,219 shares of the company’s stock valued at $42,099,000 after buying an additional 33,044 shares during the period. Xponance Inc. boosted its holdings in shares of Clorox by 2.5% during the 3rd quarter. Xponance Inc. now owns 29,343 shares of the company’s stock worth $3,846,000 after buying an additional 726 shares in the last quarter. Dakota Wealth Management grew its position in shares of Clorox by 20.0% during the 3rd quarter. Dakota Wealth Management now owns 2,642 shares of the company’s stock worth $346,000 after buying an additional 440 shares during the period. Finally, Raymond James & Associates increased its stake in shares of Clorox by 8.0% in the 3rd quarter. Raymond James & Associates now owns 306,613 shares of the company’s stock valued at $40,185,000 after acquiring an additional 22,597 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Trading Down 5.6 %

Shares of CLX stock opened at $139.64 on Thursday. The company has a debt-to-equity ratio of 11.37, a quick ratio of 0.57 and a current ratio of 0.89. The company has a market capitalization of $17.33 billion, a price-to-earnings ratio of 221.65, a PEG ratio of 2.35 and a beta of 0.43. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $178.21. The company has a 50-day simple moving average of $149.00 and a two-hundred day simple moving average of $143.10.

Clorox (NYSE:CLX) last announced its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.33 by $0.38. The firm had revenue of $1.81 billion for the quarter, compared to the consensus estimate of $1.87 billion. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The company’s revenue was down 5.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.51 EPS. Research analysts anticipate that The Clorox Company will post 5.52 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be given a dividend of $1.20 per share. This represents a $4.80 annualized dividend and a dividend yield of 3.44%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox’s dividend payout ratio is presently 761.92%.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the stock. Evercore ISI decreased their price target on shares of Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a research note on Wednesday. Citigroup decreased their target price on Clorox from $155.00 to $150.00 and set a “neutral” rating for the company in a research report on Wednesday. Morgan Stanley reaffirmed an “equal weight” rating and set a $160.00 price target on shares of Clorox in a research note on Tuesday, March 26th. Deutsche Bank Aktiengesellschaft reduced their price objective on Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a research note on Wednesday, April 17th. Finally, The Goldman Sachs Group initiated coverage on Clorox in a research report on Friday, March 1st. They set a “sell” rating and a $140.00 target price on the stock. Four analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company. According to MarketBeat.com, Clorox currently has a consensus rating of “Hold” and a consensus target price of $149.38.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.